Efficacy and safety of Macrolane™for breast enhancement: A 12-month follow-up study in Asian women
- 26 April 2013
- journal article
- Published by Taylor & Francis in Journal of Plastic Surgery and Hand Surgery
- Vol. 47 (3) , 191-195
Abstract
The demand for breast enhancement has risen substantially over recent years. Stabilised hyaluronic acid of non-animal origin manufactured using NASHA™ technology (Q-Med, Uppsala, Sweden) is an injectable gel, which has increasingly been used as a minimally invasive, non-permanent option for breast enhancement. The aim of this study was to investigate the 12-month efficacy and safety of NASHA gel, when used for breast enhancement in Asian women. Non-pregnant, non-breastfeeding women with small breasts (aged 20–50 years) were recruited into this open, prospective, non-comparative, single-centre study. Subjects received sub-glandular injections of NASHA gel. Efficacy and safety assessments were carried out at follow-up visits (1, 6, and 12 months). Physician and subject assessment of breast improvement was recorded using the Global Esthetic Improvement Scale (GEIS). Ninety-eight subjects of Asian ethnicity were enrolled; 65 subjects completed the 12-month follow-up period. Overall, a median volume of 200 mL (range 80–300 mL) NASHA gel was injected per subject. Following GEIS assessment, 79% of breasts were subject-assessed as improved, much improved, or very much improved 6 months after treatment; 48% of breasts were still considered improved after 12 months. Sub-glandular NASHA gel injection was well tolerated, eliciting no serious adverse events judged to be treatment-related. High rates of aesthetic improvement were observed for at least 6 months after NASHA gel breast enhancement. The minimally invasive injection of NASHA gel provided a treatment option, which was an attractive alternative to permanent breast implants for many women.Keywords
This publication has 13 references indexed in Scilit:
- Early clinical experience of hyaluronic acid gel for breast enhancementJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Macrolane for Breast Enhancement: 12-Month Follow-UpPlastic and Reconstructive Surgery, 2011
- Efficacy of Variable-Particle Hyaluronic Acid Dermal Fillers in Patients with Skin of ColorDermatologic Surgery, 2010
- Safety of Nonanimal Stabilized Hyaluronic Acid Dermal Fillers in Patients with Skin of ColorDermatologic Surgery, 2009
- Aesthetic Breast Surgery: Consulting for the Future—Proposals for Improving Doctor–Patient InteractionsAesthetic Plastic Surgery, 2009
- Body Shaping and Volume Restoration: The Role of Hyaluronic AcidAesthetic Plastic Surgery, 2009
- Review of the Efficacy, Durability, and Safety Data of Two Nonanimal Stabilized Hyaluronic Acid Fillers from a Prospective, Randomized, Comparative, Multicenter StudyDermatologic Surgery, 2009
- Cross-Linked Hyaluronic Acid FillersPlastic and Reconstructive Surgery, 2006
- Restylane SubQ, a non-animal stabilized hyaluronic acid gel for soft tissue augmentation of the mid- and lower faceAesthetic Surgery Journal, 2006
- Evaluation of the safety of a non‐animal stabilized hyaluronic acid (NASHA – Q‐Medical, Sweden) in European countries: a retrospective study from 1997 to 2001Journal of the European Academy of Dermatology and Venereology, 2004